Editorial: Immuno-diagnosis of active tuberculosis; are we making progress?
- PMID: 36936917
- PMCID: PMC10021700
- DOI: 10.3389/fimmu.2023.1092651
Editorial: Immuno-diagnosis of active tuberculosis; are we making progress?
Erratum in
-
Erratum: Editorial: Immuno-diagnosis of active tuberculosis; are we making progress?Front Immunol. 2023 Sep 1;14:1282008. doi: 10.3389/fimmu.2023.1282008. eCollection 2023. Front Immunol. 2023. PMID: 37727786 Free PMC article.
Keywords: current trends; future directions; immuno-diagnosis; potential markers; tuberculosis.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
-
- Chegou NN, Sutherland JS, Malherbe S, Crampin AC, Corstjens PL, Geluk A, et al. . AE-TBC consortium. diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB. Thorax (2016) 71(9):785–94. doi: 10.1136/thoraxjnl-2015-207999 - DOI - PubMed
-
- Achkar JM, Lawn SD, Moosa M-YS, Wright CA, Kasprowicz VO. Adjunctive tests for diagnosis of tuberculosis: Serology, ELISPOT for site-specific lymphocytes, urinary lipoarabinomannan, string test, and fine needle aspiration. J Infect Dis (2011) 204, Issue suppl_4:S1130–41. doi: 10.1093/infdis/jir450 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical